Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic Heterogeneity Among Carriers of the Same Pathogenic Variant in Hereditary Hemorrhagic Telangiectasia. | Genes (Basel) | 2026 | 42793006 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveal tissue-specific neutrophil heterogeneity and functional reprogramming in autoimmunity. | J Autoimmun | 2026 | 42784888 | PubTator, text mining | PubMed |
| Circulating angiogenic and inflammatory biomarkers profiling in patients with hereditary hemorrhagic telangiectasia. | Eur J Intern Med | 2026 | 42778431 | PubTator, text mining | PubMed |
| Current Paradigm Shift in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Narrative Review. | Cerebrovasc Dis | 2026 | 42776922 | PubTator, text mining | PubMed |
| Eugenol preserves chondrocyte extracellular matrix homeostasis by modulating the ALK1/ALK5-associated TGF-β/Smad signaling axis. | Front Pharmacol | 2026 | 42723961 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines from hereditary hemorrhagic telangiectasia patients harboring ACVRL1 mutations. | Stem Cell Res | 2026 | 42721788 | PubTator, text mining | PubMed |
| Solving an enigma: the BMP-9/10 axis as a key regulator of pulmonary vascular resilience. | Eur Respir J | 2026 | 42705706 | PubTator, text mining | PubMed |
| Naphthoquinones mediate differentiation of human umbilical cord derived mesenchymal stem cells into insulin producing cells through regulation of Wnt and BMP pathways. | Bioimpacts | 2026 | 42666972 | PubTator, text mining | PubMed |
| Translating evolutionary history and protein-focused machine learning supports increased prevalence of hereditary haemorrhagic telangiectasia, one of the most common inherited disorders. | QJM | 2026 | 42644811 | PubTator, text mining | PubMed |
| Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes. | Blood Vessel Thromb Hemost | 2026 | 42621902 | PubTator, text mining | PubMed |
| Tumor-Induced PDPN+ Lymphatic-like Endothelial Cells Promote Clear-Cell Renal Cell Carcinoma Progression Through Reciprocal BMP10-CXCL13 Signaling. | Int J Mol Sci | 2026 | 42589645 | PubTator, text mining | PubMed |
| Targeting KIT prevents brain arteriovenous malformations driven by ALK1-deficient angiogenic endothelial cells. | J Clin Invest | 2026 | 42579368 | PubTator, text mining | PubMed |
| A Case of High Pressure and High Stakes: Pulmonary Arterial Hypertension Emergence in an Infant With Hereditary Hemorrhagic Telangiectasia. | Pulm Circ | 2026 | 42516693 | PubTator, text mining | PubMed |
| Endothelial cannabinoid CB1 receptor deficiency reduces shear stress-induced arterial inflammation and lipid uptake. | Nat Commun | 2026 | 42414306 | PubTator, text mining | PubMed |
| Molecular-Genetic Basis of Pulmonary Arterial Hypertension (PAH). | Curr Issues Mol Biol | 2026 | 42353577 | PubTator, text mining | PubMed |
| High-grade Endometrial Stromal Sarcoma With a Novel ING3::BCOR Fusion. | Int J Gynecol Pathol | 2026 | 42296298 | PubTator, text mining | PubMed |
| Recurrent t(9;12) translocation disrupting ACVRL1 intron 9 causes hereditary haemorrhagic telangiectasia missed by standard exome sequencing in four unrelated families. | Eur J Intern Med | 2026 | 42250987 | PubTator, text mining | PubMed |
| Aggressive, Widely Metastatic Inflammatory Myofibroblastic Tumor in an Adult Presenting as an Obstructing Endobronchial Mass. | Cureus | 2026 | 42220836 | PubTator, text mining | PubMed |
| miR-141-5p positively regulates ACVRL1 expression to promote cervical cancer progression. | Hum Cell | 2026 | 42209837 | PubTator, text mining | PubMed |
| Hereditary haemorrhagic telangiectasia as a cause of exertional dyspnoea. | BMJ Case Rep | 2026 | 42209023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers